Literature DB >> 8331237

Staging of uterine endometrial carcinoma with ultra-low field (0.02 T) MRI: a comparative study with CT.

M J Varpula1, P J Klemi.   

Abstract

OBJECTIVE: The purpose of this investigation was to evaluate the capability of ultra-low field MRI for staging endometrial carcinoma.
MATERIALS AND METHODS: Computed tomography and MRI were performed on 47 patients with uterine endometrial carcinoma. The results were compared with those from clinical examination and with histopathological results after operation in 43 cases. The local extension of the endometrial carcinoma was correctly staged in 77% with clinical examination in 58% with CT, and in 88% with MRI.
RESULTS: Tumor growth was overestimated by clinical examination in 21%, by CT in 35%, and by MRI in only 5%. Magnetic resonance imaging was most accurate in detecting cervical extension and was better than CT in detecting tumor invasion to the outer half of the myometrium. The sensitivities of CT and MRI in the assessment of deep myometrial invasion were 67 and 83%, respectively, the corresponding specificities being 67 and 79%. Magnetic resonance imaging at 0.02 T was not able to differentiate tumors with superficial myometrial invasion from those confined entirely to the endometrium. The detection of metastatic lymphadenopathy was difficult with all examination methods.
CONCLUSION: Our results indicate that MRI at 0.02 T is a convenient, inexpensive, and accurate imaging method for the preoperative staging of endometrial carcinoma.

Entities:  

Mesh:

Year:  1993        PMID: 8331237     DOI: 10.1097/00004728-199307000-00023

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  7 in total

Review 1.  Management of gynaecological cancers.

Authors:  A Melville; A Eastwood; J Kleijnen; H Kitchener; P Martin-Hirsch; L Nelson
Journal:  Qual Health Care       Date:  1999-12

2.  Diagnostic Performance of Computed Tomography for Preoperative Staging of Patients with Non-endometrioid Carcinomas of the Uterine Corpus.

Authors:  Yulia Lakhman; Seth S Katz; Debra A Goldman; Derya Yakar; Hebert A Vargas; Ramon E Sosa; Maura Miccò; Robert A Soslow; Hedvig Hricak; Nadeem R Abu-Rustum; Evis Sala
Journal:  Ann Surg Oncol       Date:  2015-02-10       Impact factor: 5.344

3.  Local staging of endometrial carcinoma: role of multidetector CT.

Authors:  A C Tsili; C Tsampoulas; N Dalkalitsis; D Stefanou; E Paraskevaidis; S C Efremidis
Journal:  Eur Radiol       Date:  2008-01-04       Impact factor: 5.315

4.  Diagnostic performance of fluorodeoxyglucose positron emission tomography/magnetic resonance imaging fusion images of gynecological malignant tumors: comparison with positron emission tomography/computed tomography.

Authors:  Kazuya Nakajo; Mitsuaki Tatsumi; Atsuo Inoue; Kayako Isohashi; Ichiro Higuchi; Hiroki Kato; Masao Imaizumi; Takayuki Enomoto; Eku Shimosegawa; Tadashi Kimura; Jun Hatazawa
Journal:  Jpn J Radiol       Date:  2010-02-26       Impact factor: 2.374

Review 5.  Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer.

Authors:  Jeong-Yeol Park; Joo-Hyun Nam
Journal:  Oncologist       Date:  2015-02-11

6.  Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study.

Authors:  Stella Capriglione; Francesco Plotti; Andrea Miranda; Roberto Ricciardi; Giuseppe Scaletta; Alessia Aloisi; Federica Guzzo; Roberto Montera; Roberto Angioli
Journal:  Tumour Biol       Date:  2015-01-11

Review 7.  A systematic review of tests for lymph node status in primary endometrial cancer.

Authors:  Tara J Selman; Christopher H Mann; Javier Zamora; Khalid S Khan
Journal:  BMC Womens Health       Date:  2008-05-05       Impact factor: 2.809

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.